10x Genomics Welcomes Alan Mateo to Board of Directors
Company Announcements

10x Genomics Welcomes Alan Mateo to Board of Directors

10x Genomics (TXG) has issued an announcement.

Alan V. Mateo has been appointed to the Board of Directors of 10x Genomics, Inc. as a Class II director, with his term set to last until the 2027 annual meeting of stockholders. Mateo, an experienced executive with a strong background in sales and operations, previously served at Veeva Systems Inc. and has held various senior roles at Medidata Solutions, Inc. and PeopleSoft. His expertise is expected to be an asset to the company, bolstered by his academic qualifications in Computer Science and Marketing.

See more data about TXG stock on TipRanks’ Stock Analysis page.

Related Articles
TheFly10x Genomics price target lowered to $19 from $21 at Barclays
TheFly10x Genomics’ Visium HD selected by TechBio startup Cure51
TipRanks Auto-Generated Newsdesk10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial Maneuvering
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App